CXCL10 in the CSF, as indicators of CNS inflammation, correlate with disease progression and has been suggested as a candidate for the prognosis of HAM/TSP development (Guerreiro et al., 2006; Sato et al., 2013; Lima et al., 2017). This evidence concerns the gene CXCL10 and tropical spastic paraparesis.